Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
CENA AKCJI
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionBroderick Brian C
Latest Disclosed Ownership3,121 shares
Latest Disclosed Value $ 476,733
Broderick Brian C ownership in NOTA / Novartis AG - Depositary Receipt (Common Stock)

On May 7, 2026 - Broderick Brian C filed a 13F-HR form disclosing ownership of 3,121 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $401,048 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 3,121 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 0.00% during the quarter. The current value of the position is $377,641 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F NOVARTIS AG ADR COM 66987V109 3,121 0 0.00 477 10.70 0.0177
2026-02-13 2025-12-31 13F NOVARTIS AG ADR COM 66987V109 3,121 0 0.00 430 7.50 0.0813
2025-11-10 2025-09-30 13F NOVARTIS AG ADR COM 66987V109 3,121 -1,082 -25.74 400 -21.26 0.0760
2025-07-23 2025-06-30 13F NOVARTIS AG ADR COM 66987V109 4,203 -70 -1.64 509 6.72 0.1006
2025-04-18 2025-03-31 13F NOVARTIS AG ADR COM 66987V109 4,273 -3,800 -47.07 476 -39.36 0.0970
2025-02-13 2024-12-31 13F NOVARTIS AG ADR COM 66987V109 8,073 -3,960 -32.91 786 -43.28 0.1541
2024-11-06 2024-09-30 13F NOVARTIS AG ADR COM 66987V109 12,033 -6,780 -36.04 1,384 -30.87 0.2709
2024-08-12 2024-06-30 13F NOVARTIS AG ADR COM 66987V109 18,813 -3,021 -13.84 2,003 -5.21 0.4089
2024-05-06 2024-03-31 13F NOVARTIS AG ADR COM 66987V109 21,834 -6,126 -21.91 2,112 -25.19 0.4511
2024-02-14 2023-12-31 13F NOVARTIS AG ADR COM 66987V109 27,960 -1,055 -3.64 2,823 -4.47 0.7046
2023-11-14 2023-09-30 13F NOVARTIS AG ADR COM 66987V109 29,015 1,425 5.16 2,955 6.14 0.8143
2023-08-11 2023-06-30 13F NOVARTIS AG ADR COM 66987V109 27,590 -360 -1.29 2,784 8.28 0.7346
2023-05-10 2023-03-31 13F NOVARTIS AG ADR COM 66987V109 27,950 -525 -1.84 2,571 -0.46 0.7218
2023-02-09 2022-12-31 13F NOVARTIS AG ADR COM 66987V109 28,475 -1,930 -6.35 2,583 11.77 0.7663
2022-11-08 2022-09-30 13F NOVARTIS AG ADR COM 66987V109 30,405 -1,980 -6.11 2,311 -15.56 0.7222
2022-07-19 2022-06-30 13F NOVARTIS AG ADR COM 66987V109 32,385 -3,848 -10.62 2,737 -13.90 0.8300
2022-05-17 2022-03-31 13F NOVARTIS AG ADR COM 66987V109 36,233 -4,867 -11.84 3,179 -11.57 0.8122
2022-02-08 2021-12-31 13F NOVARTIS AG ADR COM 66987V109 41,100 -27,295 -39.91 3,595 -35.72 0.8645
2021-11-10 2021-09-30 13F NOVARTIS AG ADR COM 66987V109 68,395 -12,109 -15.04 5,593 -23.84 1.4928
2021-08-09 2021-06-30 13F NOVARTIS AG ADR COM 66987V109 80,504 -4,869 -5.70 7,344 0.64 1.9507
2021-05-17 2021-03-31 13F NOVARTIS AG ADR COM 66987V109 85,373 -847 -0.98 7,297 -10.39 2.1001
2021-02-16 2020-12-31 13F NOVARTIS AG ADR COM 66987V109 86,220 -425 -0.49 8,143 8.07 2.4175
2020-10-28 2020-09-30 13F NOVARTIS AG ADR COM 66987V109 86,645 941 1.10 7,535 0.67 2.3979
2020-07-28 2020-06-30 13F NOVARTIS AG ADR COM 66987V109 85,704 -683 -0.79 7,485 5.08 2.4923
2020-05-07 2020-03-31 13F NOVARTIS AG ADR COM 66987V109 86,387 212 0.25 7,123 -12.71 2.8181
2020-01-15 2019-12-31 13F NOVARTIS AG ADR COM 66987V109 86,175 -627 -0.72 8,160 8.18 2.6434
2019-11-04 2019-09-30 13F NOVARTIS AG ADR COM 66987V109 86,802 -663 -0.76 7,543 -5.55 2.5948
2019-07-24 2019-06-30 13F NOVARTIS AG ADR COM 66987V109 87,465 -130 -0.15 7,986 -5.18 2.7938
2019-04-29 2019-03-31 13F NOVARTIS AG ADR COM 66987V109 87,595 -1,532 -1.72 8,422 10.13 3.0087
2019-01-24 2018-12-31 13F NOVARTIS AG ADR COM 66987V109 89,127 -2,402 -2.62 7,647 -3.04 3.2177
2018-10-15 2018-09-30 13F NOVARTIS AG ADR COM 66987V109 91,529 262 0.29 7,887 14.44 2.6751
2018-07-30 2018-06-30 13F NOVARTIS AG ADR COM 66987V109 91,267 1,020 1.13 6,892 -5.56 2.5193
2018-04-24 2018-03-31 13F NOVARTIS AG ADR COM 66987V109 90,247 42 0.05 7,298 -3.64 2.7366
2018-02-02 2017-12-31 13F NOVARTIS AG ADR COM 66987V109 90,205 -4,032 -4.28 7,574 -6.39 2.7647
2017-10-26 2017-09-30 13F NOVARTIS AG ADR COM 66987V109 94,237 1,688 1.82 8,091 4.71 2.9195
2017-07-21 2017-06-30 13F NOVARTIS AG ADR COM 66987V109 92,549 1,910 2.11 7,727 14.78 2.8588
2017-05-16 2017-03-31 13F NOVARTIS AG ADR COM 66987V109 90,639 1,983 2.24 6,732 4.23 2.7459
2017-02-14 2016-12-31 13F NOVARTIS AG ADR Common Stock 66987V109 88,656 -480 -0.54 6,459 -8.24 2.7987
2016-11-16 2016-09-30 13F NOVARTIS AG ADR Common Stock 66987V109 89,136 -1,390 -1.54 7,039 -5.76 2.9999
2016-08-08 2016-06-30 13F NOVARTIS AG ADR Common Stock 66987V109 90,526 3,195 3.66 7,469 18.05 3.1421
2016-05-27 2016-03-31 13F NOVARTIS AG ADR Common Stock 66987V109 87,331 6,430 7.95 6,327 -9.08 2.7396
2016-02-12 2015-12-31 13F NOVARTIS AG ADR Common Stock 66987V109 80,901 -108 -0.13 6,959 -6.54 3.1141
2015-11-13 2015-09-30 13F NOVARTIS AG ADR Common Stock 66987V109 81,009 190 0.24 7,446 -6.34 3.4487
2015-08-10 2015-06-30 13F NOVARTIS AG ADR Common Stock 66987V109 80,819 -1,211 -1.48 7,950 -1.71 3.3864
2015-05-22 2015-03-31 13F NOVARTIS AG ADR Common Stock 66987V109 82,030 660 0.81 8,088 7.28 3.3559
2015-02-13 2014-12-31 13F NOVARTIS AG ADR Common Stock 66987V109 81,370 5,425 7.14 7,539 5.47 3.1940
2014-11-24 2014-09-30 13F NOVARTIS AG ADR Common Stock 66987V109 75,945 591 0.78 7,148 4.78 3.1801
2014-07-23 2014-06-30 13F NOVARTIS AG ADR Common Stock 66987V109 75,354 2,205 3.01 6,822 9.70 3.1234
2014-05-29 2014-03-31 13F NOVARTIS AG ADR Common Stock 66987V109 73,149 10 0.01 6,219 5.78 3.0573
2014-02-27 2013-12-31 13F NOVARTIS AG ADR Common Stock 66987V109 73,139 -500 -0.68 5,879 4.07 2.9268
2013-11-18 2013-09-30 13F NOVARTIS AG ADR Common Stock 66987V109 73,639 -25 -0.03 5,649 8.47 3.1504
2013-08-16 2013-06-30 13F NOVARTIS AG ADR Common Stock 66987V109 73,664 340 0.46 5,208 -0.33 3.1150
2013-08-16 2013-03-31 13F NOVARTIS AG ADR Common Stock 66987V109 73,324 2,620 3.71 5,225 16.73 3.1004
2013-08-16 2012-12-31 13F NOVARTIS AG ADR Common Stock 66987V109 70,704 70,704 4,476 3.1720
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.